(R)-Roscovitine-d7

• UNSPSC Description:

  (R)-Roscovitine-d7 (Seliciclib-d7; CYC202-d7) is deuterium-labeled (R)-Roscovitine (HY-30237)[1].

• Target Antigen:

  CDK; Isotope-Labeled Compounds

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Cell Cycle/DNA Damage;Others

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Smiles:

  OC[C@H](NC1=NC(NCC2=CC=CC=C2)=C3C(N(C=N3)C(C([2H])([2H])[2H])([2H])C([2H])([2H])[2H])=N1)CC

• Molecular Weight:

  361.49

• References & Citations:

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.|[2]Smith K A, et al. Soil and environmental analysis[M]. Marcel Dekker Incorporated, 2000.|[3]Fan T W M, et al. Stable isotope-resolved metabolomics and applications for drug development[J]. Pharmacology & therapeutics, 2012, 133(3): 366-391.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported